Qiong Wang

Dr. Qiong Wang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
RJRuimei Jin
Ruimei Jin
XYXiaoquan Yang
Xiaoquan Yang
DZDonghui Zhao
Donghui Zhao
XHXiaolin Hou
Xiaolin Hou
CLChaoqing Li
Chaoqing Li
BLBo Liu
Bo Liu
An injectable multifunctional hydrogel based on an engineered polypeptide, Ag2S quantum dots, and paclitaxel has been developed for sustained chemo-photothermal therapy.

5 March 2019 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
DZDong-Hui Zhao
Dong-Hui Zhao
XYXiao-Quan Yang
Xiao-Quan Yang
XHXiao-Lin Hou
Xiao-Lin Hou
YXYang Xuan
Yang Xuan
XSXian-Lin Song
Xian-Lin Song
BLBo Liu
Bo Liu
Ag2S quantum dots have received extensive attention as theranostic agents for second near-infrared (NIR-II) fluorescence and photoacoustic dual-mode imaging, and photothermal therapy. However, it is still greatly challenging to synthesize Ag2S quantum dots using aqueous synthesis. In this study, genetically engineered polypeptide-capped Ag2S quantum dots were successfully synthesized. Three cysteines were integrated to the C-terminal and N-terminal of RGDPC10A to enhance the stability and brightness of the synthesized Ag2S quantum dots. The RGDPC10A-capped Ag2S quantum dots exhibited excellent stability, outstanding resistance to photobleaching, and a superior quantum yield of up to 3.78% in the NIR-II biological window. The in vitro and in vivo results showed that the RGDPC10A-capped Ag2S quantum dots possessed typical NIR-II fluorescence, photoacoustic imaging, and photothermal therapeutic effectiveness against tumors. Moreover, the results of toxicity assays suggested that the RGDPC10A-capped Ag2S quantum dots have negligible long-term toxicity. These findings open up the possibility for synthesizing theranostic agents by using this aqueous method.

12 June 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
YXYuxiu Xie
Yuxiu Xie
THTing Hu
Ting Hu
RCRenwang Chen
Renwang Chen
HCHaiyan Chang
Haiyan Chang
QWQiong Wang
Qiong Wang
JCJing Cheng
Jing Cheng
Background: Acute radiation dermatitis (ARD) is one of the most common acute adverse reactions in breast cancer patients during and immediately after radiotherapy. As ARD affects patient quality of life, it is important to conduct individualized risk assessments of patients in order to identify those patients most at risk of developing severe ARD. Methods: The data of breast cancer patients who received radiotherapy were prospectively collected and analyzed. Serum ferritin, high-sensitivity C-reactive protein (hs-CRP) levels, and percentages of lymphocyte subsets were measured before radiotherapy. ARD was graded (0–6 grade), according to the Oncology Nursing Society Skin Toxicity Scale. Univariate and multivariate logistic regression analyses were used and the odds ratio (OR) and 95% confidence interval (CI) of each factor were calculated. Results: This study included 455 breast cancer patients. After radiotherapy, 59.6% and 17.8% of patients developed at least 3 (3+) grade and at least 4 (4+) grade ARD, respectively. Multivariate logistic regression analysis found that body mass index (OR: 1.11, 95% CI: 1.01–1.22), diabetes (OR: 2.70, 95% CI: 1.11–6.60), smoking (OR: 3.04, 95% CI: 1.15–8.02), higher ferritin (OR: 3.31, 95% CI: 1.78–6.17), higher hs-CRP (OR: 1.96, 95% CI: 1.02–3.77), and higher CD3 + T cells (OR: 2.99, 95% CI: 1.10–3.58) were independent risk factors for 4 + grade ARD. Based on these findings, a nomogram model of 4 + grade ARD was further established. The nomogram AUC was 0.80 (95% CI: 0.75–0.86), making it more discriminative than any single factor. Conclusion: BMI, diabetes, smoking history, higher ferritin, higher hs-CRP, and higher CD3 + T cells prior to radiotherapy for breast cancer are all independent risk factors for 4 + grade ARD. The results can provide evidence for clinicians to screen out high-risk patients, take precautions and carefully follow up on these patients before and during radiotherapy.

26 December 2018 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
ZYZhongyuan Yin
Zhongyuan Yin
GYGuanghai Yang
Guanghai Yang
SDSisi Deng
Sisi Deng
QWQiong Wang
Qiong Wang
The purpose of this study was to set up a beagle dog model, for radiation-induced lung injury, that would be able to supply fresh lung tissues in the different injury phases for research into oxidative stress levels and mitochondrial gene expression. Blood serum and tissues were collected via CT-guided core needle biopsies from dogs in the various phases of the radiation response over a 40-week period. Levels of reactive oxygen species (ROS) and manganese superoxide dismutase 2 (MnSOD) protein expression in radiation-induced lung injury were determined by in situ immunocytochemistry; malondialdehyde (MDA) content and reductase activity in the peripheral blood were also tested; in addition, the copy number of the mitochondrial DNA and the level of function of the respiratory chain in the lung tissues were assessed. ROS showed dynamic changes and peaked at 4 weeks; MnSOD was mainly expressed in the Type II alveolar epithelium at 8 weeks; the MDA content and reductase activity in the peripheral blood presented no changes; the copy numbers of most mitochondrial genes peaked at 8 weeks, similarly to the level of function of the corresponding respiratory chain complexes; the level of function of the respiratory chain complex III did not peak until 24 weeks, similarly to the level of function of the corresponding gene Cytb. Radiation-induced lung injury was found to be a dynamically changing process, mainly related to interactions between local ROS, and it was not associated with the levels of oxidative stress in the peripheral blood. Mitochondrial genes and their corresponding respiratory chain complexes were found to be involved in the overall process.

3 December 2018 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
QXQun Xiang
Qun Xiang
WJWuyun Jie
Wuyun Jie
KZKuiKui Zhu
KuiKui Zhu
QWQiong Wang
Qiong Wang
JCJing Cheng
Jing Cheng
Purpose: Our purpose was to explore which immobilization is more suitable for clinical practice in postmastectomy intensity modulation radiotherapy, the single‐pole position or the double‐pole position?Methods: Patients treated with postmastectomy intensity modulation radiotherapy were eligible. They were selected randomly for single‐pole position or double‐pole position. Dose–volume histogram (DVH) was used to evaluate plans. After their first radiotherapy, the physicians asked a question about the comfort level of their position. The dosimetric parameters, comfort levels, and reproducibility of the two immobilization techniques were collected and analyzed after all patients had finished the whole radiotherapy.Results: Totally, 94 patients were enrolled. Of these, 54 patients were treated with the single‐pole position, 28 (51.9%)had left‐sided lesions. While 40 patients were treated with the double‐pole position, 20 (50%) had left‐sided lesions. Patients’ characteristics in two groups were comparable. The single‐pole and double‐pole immobilizations had similar conformity (0.60 ± 0.05 vs 0.60 ± 0.06, P = 0.887) and homogeneity index (0.14 ± 0.03 vs 0.13 ± 0.03, P = 0.407). Compared to single‐pole position, double‐pole position typically increased the mean dose, V20, and V30 of heart (P < 0.05). Moreover, patients in the single‐pole group felt more comfortable than another group (P < 0.05). There was no difference in reproducibility between the two groups (P > 0.05).Conclusions: Single‐pole position seems to be more comfortable and can reduce dose coverage to heart. Both devices allow for reproducible setup and acceptable dosimetry.

3 January 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
ZYZhongyuan Yin
Zhongyuan Yin
ZLZhiwen Liang
Zhiwen Liang
PLPengcheng Li
Pengcheng Li
QWQiong Wang
Qiong Wang